As the panel discussion concludes, expert panelists share their final insights about the current US healthcare system and its initiatives to combat cardiovascular disease and cardiometabolic events.
David Calabrese, RPh, MHP, explains that although challenges exist they are not “insurmountable.” He believes that in order to overcome the current treatment barriers, a patient-centric approach is necessary when caring for patients.
Kenneth L. Schaecher, MD, FACP, CPC, and Yehuda Handelsman, MD, FACP, FACE, FNLA, agree that medicine is at an exciting era in the US, as new innovations provide additional tools to help coordinate care between clinicians and their patients. However, Dr Handelsman reminds that the US needs to develop programs that help pay for the expensive costs of healthcare.
Michael Weber, MD, concludes the discussion by defining preventive medicine and explains its importance when managing cardiometabolic conditions.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More